These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30260541)

  • 1. Differential escape of HCV from CD8
    Xia Y; Pan W; Ke X; Skibbe K; Walker A; Hoffmann D; Lu Y; Yang X; Feng X; Tong Q; Timm J; Yang D
    J Viral Hepat; 2019 Jan; 26(1):73-82. PubMed ID: 30260541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.
    Ruhl M; Chhatwal P; Strathmann H; Kuntzen T; Bankwitz D; Skibbe K; Walker A; Heinemann FM; Horn PA; Allen TM; Hoffmann D; Pietschmann T; Timm J
    J Virol; 2012 Jan; 86(2):991-1000. PubMed ID: 22072759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 epitope escape and reversion in acute HCV infection.
    Timm J; Lauer GM; Kavanagh DG; Sheridan I; Kim AY; Lucas M; Pillay T; Ouchi K; Reyor LL; Schulze zur Wiesch J; Gandhi RT; Chung RT; Bhardwaj N; Klenerman P; Walker BD; Allen TM
    J Exp Med; 2004 Dec; 200(12):1593-604. PubMed ID: 15611288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins.
    Ruhl M; Knuschke T; Schewior K; Glavinic L; Neumann-Haefelin C; Chang DI; Klein M; Heinemann FM; Tenckhoff H; Wiese M; Horn PA; Viazov S; Spengler U; Roggendorf M; Scherbaum N; Nattermann J; Hoffmann D; Timm J;
    Gastroenterology; 2011 Jun; 140(7):2064-73. PubMed ID: 21376049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells.
    Ziegler S; Skibbe K; Walker A; Ke X; Heinemann FM; Heinold A; Mok JY; van Esch WJ; Yang D; Wölfl M; Timm J
    J Virol; 2014 Oct; 88(19):11080-90. PubMed ID: 25008925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
    Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level.
    Neumann-Haefelin C; Frick DN; Wang JJ; Pybus OG; Salloum S; Narula GS; Eckart A; Biezynski A; Eiermann T; Klenerman P; Viazov S; Roggendorf M; Thimme R; Reiser M; Timm J
    J Virol; 2008 Apr; 82(7):3438-51. PubMed ID: 18216107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs.
    Salloum S; Oniangue-Ndza C; Neumann-Haefelin C; Hudson L; Giugliano S; aus dem Siepen M; Nattermann J; Spengler U; Lauer GM; Wiese M; Klenerman P; Bright H; Scherbaum N; Thimme R; Roggendorf M; Viazov S; Timm J
    J Virol; 2008 Dec; 82(23):11803-12. PubMed ID: 18815309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection.
    Fitzmaurice K; Petrovic D; Ramamurthy N; Simmons R; Merani S; Gaudieri S; Sims S; Dempsey E; Freitas E; Lea S; McKiernan S; Norris S; Long A; Kelleher D; Klenerman P
    Gut; 2011 Nov; 60(11):1563-71. PubMed ID: 21551190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of T-cell epitopes of hepatitis C virus genotype 5a.
    Gededzha MP; Mphahlele MJ; Selabe SG
    Virol J; 2014 Nov; 11():187. PubMed ID: 25380768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of CD4
    Lucas M; Deshpande P; James I; Rauch A; Pfafferott K; Gaylard E; Merani S; Plauzolles A; Lucas A; McDonnell W; Kalams S; Pilkinton M; Chastain C; Barnett L; Prosser A; Mallal S; Fitzmaurice K; Drummer H; Ansari MA; Pedergnana V; Barnes E; John M; Kelleher D; Klenerman P; Gaudieri S
    Sci Rep; 2018 May; 8(1):7224. PubMed ID: 29740042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
    Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.
    Neumann-Haefelin C; Oniangue-Ndza C; Kuntzen T; Schmidt J; Nitschke K; Sidney J; Caillet-Saguy C; Binder M; Kersting N; Kemper MW; Power KA; Ingber S; Reyor LL; Hills-Evans K; Kim AY; Lauer GM; Lohmann V; Sette A; Henn MR; Bressanelli S; Thimme R; Allen TM
    Hepatology; 2011 Oct; 54(4):1157-66. PubMed ID: 22006856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8
    Karimzadeh H; Kiraithe MM; Oberhardt V; Salimi Alizei E; Bockmann J; Schulze Zur Wiesch J; Budeus B; Hoffmann D; Wedemeyer H; Cornberg M; Krawczyk A; Rashidi-Alavijeh J; Rodríguez-Frías F; Casillas R; Buti M; Smedile A; Alavian SM; Heinold A; Emmerich F; Panning M; Gostick E; Price DA; Timm J; Hofmann M; Raziorrouh B; Thimme R; Protzer U; Roggendorf M; Neumann-Haefelin C
    Gastroenterology; 2019 May; 156(6):1820-1833. PubMed ID: 30768983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.
    Nitschke K; Barriga A; Schmidt J; Timm J; Viazov S; Kuntzen T; Kim AY; Lauer GM; Allen TM; Gaudieri S; Rauch A; Lange CM; Sarrazin C; Eiermann T; Sidney J; Sette A; Thimme R; López D; Neumann-Haefelin C
    J Hepatol; 2014 Jan; 60(1):22-9. PubMed ID: 23978718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized vaccination regimen linked to exhaustive screening approaches identifies 2 novel HLA-B7 restricted epitopes within hepatitis C virus NS3 protein.
    Martin P; Parroche P; Pajot A; Chatel L; Barreto C; Touat L; Dubois V; Rohrlich PS; Bain C; Trépo C; Negro F; Inchauspé G; Fournillier A
    Microbes Infect; 2006 Aug; 8(9-10):2432-41. PubMed ID: 16859951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural in silico analysis of cross-genotype-reactivity among naturally occurring HCV NS3-1073-variants in the context of HLA-A*02:01 allele.
    Antunes DA; Rigo MM; Silva JP; Cibulski SP; Sinigaglia M; Chies JA; Vieira GF
    Mol Immunol; 2011 Jul; 48(12-13):1461-7. PubMed ID: 21513985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.
    Lichterfeld M; Williams KL; Mui SK; Shah SS; Mothe BR; Sette A; Kim A; Johnston MN; Burgett N; Frahm N; Cohen D; Brander C; Rosenberg ES; Walker BD; Altfeld M; Yu XG
    Int Immunol; 2006 Jul; 18(7):1179-88. PubMed ID: 16772368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.